Literature DB >> 22223254

Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.

Takashi Funatogawa1, Ikuko Funatogawa, Yu Shyr.   

Abstract

When primary endpoints of randomized trials are continuous variables, the analysis of covariance (ANCOVA) with pre-treatment measurements as a covariate is often used to compare two treatment groups. In the ANCOVA, equal slopes (coefficients of pre-treatment measurements) and equal residual variances are commonly assumed. However, random allocation guarantees only equal variances of pre-treatment measurements. Unequal covariances and variances of post-treatment measurements indicate unequal slopes and, usually, unequal residual variances. For non-normal data with unequal covariances and variances of post-treatment measurements, it is known that the ANCOVA with equal slopes and equal variances using an ordinary least-squares method provides an asymptotically normal estimator for the treatment effect. However, the asymptotic variance of the estimator differs from the variance estimated from a standard formula, and its property is unclear. Furthermore, the asymptotic properties of the ANCOVA with equal slopes and unequal variances using a generalized least-squares method are unclear. In this paper, we consider non-normal data with unequal covariances and variances of post-treatment measurements, and examine the asymptotic properties of the ANCOVA with equal slopes using the variance estimated from a standard formula. Analytically, we show that the actual type I error rate, thus the coverage, of the ANCOVA with equal variances is asymptotically at a nominal level under equal sample sizes. That of the ANCOVA with unequal variances using a generalized least-squares method is asymptotically at a nominal level, even under unequal sample sizes. In conclusion, the ANCOVA with equal slopes can be asymptotically justified under random allocation.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2011        PMID: 22223254      PMCID: PMC5663204          DOI: 10.1002/bimj.201000200

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  9 in total

1.  The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.

Authors:  W J Rogan; K N Dietrich; J H Ware; D W Dockery; M Salganik; J Radcliffe; R L Jones; N B Ragan; J J Chisolm; G G Rhoads
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

2.  Committee for Proprietary Medicinal Products (CPMP): points to consider on adjustment for baseline covariates.

Authors: 
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

3.  Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.

Authors:  Bjorn Winkens; Gerard J P van Breukelen; Hubert J A Schouten; Martijn P F Berger
Journal:  Contemp Clin Trials       Date:  2007-04-21       Impact factor: 2.226

4.  The effect of screening on some pretest-posttest test variances.

Authors:  D A Follmann
Journal:  Biometrics       Date:  1991-06       Impact factor: 2.571

5.  An approximate distribution of estimates of variance components.

Authors:  F E SATTERTHWAITE
Journal:  Biometrics       Date:  1946-12       Impact factor: 2.571

6.  Analysis of covariance in parallel-group clinical trials with pretreatment baselines.

Authors:  M R Crager
Journal:  Biometrics       Date:  1987-12       Impact factor: 2.571

7.  Optimum sample sizes for the comparison of the control and treatment.

Authors:  J M Nam
Journal:  Biometrics       Date:  1973-03       Impact factor: 2.571

8.  How many controls?

Authors:  M Gail; R Williams; D P Byar; C Brown
Journal:  J Chronic Dis       Date:  1976-11

9.  Covariance analyses with heterogeneity of slopes in fixed models.

Authors:  L J Hendrix; M W Carter; D T Scott
Journal:  Biometrics       Date:  1982-09       Impact factor: 2.571

  9 in total
  2 in total

1.  Longitudinal analysis of pre- and post-treatment measurements with equal baseline assumptions in randomized trials.

Authors:  Ikuko Funatogawa; Takashi Funatogawa
Journal:  Biom J       Date:  2019-08-08       Impact factor: 2.207

2.  Data analysis methods for assessing palliative care interventions in one-group pre-post studies.

Authors:  Takeshi Ioroi; Tatsuyuki Kakuma; Akihiro Sakashita; Yuki Miki; Kanako Ohtagaki; Yuka Fujiwara; Yuko Utsubo; Yoshihiro Nishimura; Midori Hirai
Journal:  SAGE Open Med       Date:  2015-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.